Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1998 5
1999 6
2000 4
2001 10
2002 7
2003 5
2004 4
2005 5
2006 2
2007 3
2008 3
2009 2
2010 4
2011 4
2012 5
2013 8
2014 5
2015 5
2016 2
2017 5
2018 4
2019 7
2020 4
2021 10
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.
Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I. Chollet F, et al. Among authors: thalamas c. Lancet Neurol. 2011 Feb;10(2):123-30. doi: 10.1016/S1474-4422(10)70314-8. Epub 2011 Jan 7. Lancet Neurol. 2011. PMID: 21216670 Clinical Trial.
Manuel de bonnes pratiques professionnelles des centres d'investigation clinique.
Cornu C, Camberlein C, Binquet C, Robert C, Vigouroux C, Bouyssou C, Felin A, Dupont-Mordelet MF, Sailly A, Kubiak C, Poli G, Gueguen S, Duchesne C, Ploix S, Thalamas C. Cornu C, et al. Among authors: thalamas c. Therapie. 2012 Jan-Feb;67(1):11-42. doi: 10.2515/therapie/2012006. Therapie. 2012. PMID: 27393657 French.
Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer's disease.
Gouilly D, Salabert AS, Bertrand E, Goubeaud M, Catala H, Germain J, Ainaoui N, Rafiq M, Benaiteau M, Carlier J, Nogueira L, Planton M, Hitzel A, Méligne D, Sarton B, Silva S, Lemesle B, Payoux P, Thalamas C, Péran P, Pariente J. Gouilly D, et al. Among authors: thalamas c. Front Neurol. 2023 Jul 31;14:1189278. doi: 10.3389/fneur.2023.1189278. eCollection 2023. Front Neurol. 2023. PMID: 37588670 Free PMC article.
Mismatch Profile Influences Outcome After Mechanical Thrombectomy.
Olivot JM, Albucher JF, Guenego A, Thalamas C, Mlynash M, Rousseau V, Drif A, Christensen S, Sommet A, Viguier A, Darcourt J, Calvière L, Menegon P, Raposo N, Januel AC, Bonneville F, Tourdias T, Mazighi M, Sibon I, Albers GW, Cognard C; FRAME Investigators*. Olivot JM, et al. Among authors: thalamas c. Stroke. 2021 Jan;52(1):232-240. doi: 10.1161/STROKEAHA.120.031929. Epub 2020 Dec 22. Stroke. 2021. PMID: 33349010
Broad white matter impairment in multiple system atrophy.
Del Campo N, Phillips O, Ory-Magne F, Brefel-Courbon C, Galitzky M, Thalamas C, Narr KL, Joshi S, Singh MK, Péran P, Pavy-LeTraon A, Rascol O. Del Campo N, et al. Among authors: thalamas c. Hum Brain Mapp. 2021 Feb 1;42(2):357-366. doi: 10.1002/hbm.25227. Epub 2020 Oct 16. Hum Brain Mapp. 2021. PMID: 33064319 Free PMC article.
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: thalamas c. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
What predicts poor outcome after successful thrombectomy in early time window?
Olivot JM, Heit JJ, Mazighi M, Raposo N, Albucher JF, Rousseau V, Guenego A, Thalamas C, Mlynash M, Drif A, Christensen S, Sommet A, Viguier A, Darcourt J, Januel AC, Calviere L, Menegon P, Caparros F, Bonneville F, Tourdias T, Sibon I, Albers GW, Cognard C; FRAME Investigators. Olivot JM, et al. Among authors: thalamas c. J Neurointerv Surg. 2022 Nov;14(11):1051-1055. doi: 10.1136/neurintsurg-2021-017946. Epub 2021 Nov 8. J Neurointerv Surg. 2022. PMID: 34750109
Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.
Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Rigal E, Danet L, Pariente J, Schmitt L, Arbus C, Péran P. Yrondi A, et al. Among authors: thalamas c. J Affect Disord. 2019 Nov 1;258:42-49. doi: 10.1016/j.jad.2019.07.075. Epub 2019 Jul 31. J Affect Disord. 2019. PMID: 31382103
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group. Rascol O, et al. Among authors: thalamas c. Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1. Mov Disord. 2021. PMID: 33792958 Free article. Clinical Trial.
Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core.
Seners P, Oppenheim C, Turc G, Albucher JF, Guenego A, Raposo N, Christensen S, Calvière L, Viguier A, Darcourt J, Januel AC, Mlynash M, Sommet A, Thalamas C, Sibon I, Rousseau V, Tourdias T, Menegon P, Bonneville F, Mazighi M, Charron S, Legrand L, Cognard C, Albers GW, Baron JC, Olivot JM; FRAME investigators. Seners P, et al. Among authors: thalamas c. Ann Neurol. 2021 Sep;90(3):417-427. doi: 10.1002/ana.26152. Epub 2021 Jul 29. Ann Neurol. 2021. PMID: 34216396 Free article. Clinical Trial.
110 results